2016-03-13T00:00:00.000-05:00
analysts,0.504652
reports earnings,-0.30474
S&P500,-0.470235
California-based fund,0.257644
clinical-stage biopharmaceutical company,0.28765
email newsletter,0.580274
rational design,0.720287
Inc.,0.367485
traditional chemotherapies,0.720287
stock,0.279604
North Carolina-based Bank,0.20627
anti-cancer activity,0.64942
negative earnings,-0.772623
Capital Management,0.44732
Receive News,0.398382
email address,0.504652
technology platform,0.360295
Caxton Corp,0.424424
Celator Pharmaceuticals,0.424424
latest news,0.504652
portfolio,0.435872
Valence Life Sciences,0.543835
Gp Ii Llc,0.543835
Rotella Capital Management,0.44732
rapid evaluation,0.720287
Ratings Via Email,0.398382
institutional sentiment,-0.204821
shares,0.481938
concise daily summary,0.504652
MLV,0.352938
America Corp,0.20627
Jackson Scott Thomas,0.651632
Powell Fred,0.56677
